HGH Fragment 176-191 — Dosing, Cycles, Half-Life & Side Effects

HGH Fragment 176-191 is a growth hormone fragment peptide with a half-life of 30 minutes. The lipolytic fragment of human growth hormone (amino acids 176-191). Promotes fat burning by stimulating lipolysis and inhibiting lipogenesis without the growth-promoting or diabetogenic effects of full HGH. This page is educational harm-reduction reference compiled from peer-reviewed literature — not medical advice, not an endorsement, not a recommendation to use. Consult a licensed clinician before any decision.

Quick Facts

ClassGH Fragments / Fat Loss Peptides
Half-life30 minutes
HepatotoxicityNone
Suppression0/10

Typical Dosing Ranges

Common dose range: 250-500mcg twice daily (AM fasted, pre-bed)

Cycle length: 8-12 weeks

Dose ranges are compiled from published pharmacokinetic studies and community-reported usage. Where a value is community-reported rather than clinically studied, this page and its structured data flag it. Lower end of any range is always the safer starting point.

Stacking Considerations

  • No structural stacking blockers. Standard harm-reduction rules apply: minimize total androgen load, minimize oral exposure, and monitor bloodwork.

PCT Requirements

  • Never stack two SERMs. Extend a single SERM (tamoxifen OR enclomiphene/clomiphene) rather than combining.
  • Use the cycle planner to generate a full protocol based on your complete stack, not this compound alone.

Side Effect Profile

  • Very short half-life
  • Requires multiple daily injections
  • Must be taken fasted
  • Expensive
  • Limited human clinical data

Known Interactions

  • mk677 + HGH Fragment 176-191

    minorsynergistic

    MK-677 and GH both increase GH/IGF-1. May cause excessive GH-related sides.

    Recommendation: Generally redundant. Choose one for cost-effectiveness.

    Monitor: IGF-1, Blood glucose, Water retention

Monitoring (Bloodwork & Vitals)

  • Comprehensive metabolic panel (baseline, mid-cycle, post-cycle)
  • Lipid panel (total cholesterol, HDL, LDL, triglycerides)
  • CBC (hemoglobin, hematocrit — watch for erythrocytosis)
  • Sex-hormone panel (Total T, Free T, Estradiol sensitive, SHBG, LH, FSH)
  • Blood pressure (weekly self-check; flag systolic >140 or diastolic >90)

Baseline bloodwork is recommended before any cycle. Discontinue if liver enzymes exceed 3× upper limit of normal or if hematocrit exceeds 54%.

Frequently Asked Questions

What is the half-life of HGH Fragment 176-191?

HGH Fragment 176-191 has a half-life of approximately 30 minutes. This figure is used to determine injection frequency (for esters) and post-cycle clearance timing.

What is the typical dose range for HGH Fragment 176-191?

Commonly reported ranges for HGH Fragment 176-191: 250-500mcg twice daily (AM fasted, pre-bed). Cycle length: 8-12 weeks. These are compiled from published studies and community-reported usage — individual response varies and lower end is always preferred.

Does HGH Fragment 176-191 suppress natural testosterone?

HGH Fragment 176-191 causes minimal suppression of the HPTA axis (score 0/10). PCT may still be advisable depending on stack and duration.

What is HGH Fragment 176-191 typically used for?

HGH Fragment 176-191 is commonly used for: Fat loss, Cutting, Contest preparation. Intended-use context does not imply safety — every use case carries the same underlying pharmacological risks.

Is HGH Fragment 176-191 legal?

HGH Fragment 176-191 is a controlled substance in many jurisdictions (typically Schedule III in the US when it is an anabolic androgenic steroid). StackItSmart does not provide sourcing information. Possession, import, and use without a prescription carry legal consequences that vary by country and state.

Citations

  1. Ng FM et al.. 2000. Horm Res — GH fragment 176-191 stimulates lipolysis; limited human data

Disclaimer

StackItSmart is an independent harm-reduction reference. The content above is compiled from peer-reviewed literature and is not medical advice, not an endorsement, and not a recommendation to use HGH Fragment 176-191. Performance-enhancing compounds carry legal, endocrine, cardiovascular, and hepatic risks. Consult a licensed clinician before any decision. StackItSmart does not provide sourcing, procurement, or dosing prescriptions.

Skip to main content